Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josef J Fox

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 4, 2016
Evaluation of Castration-Resistant Prostate Cancer with Androgen Receptor-Axis ImagingNeeta Pandit-Taskar, Darren R Veach, Josef J Fox, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 5, 2023
Long-Term Prognostic Value of <sup>82</sup>Rb PET/CT-Determined Myocardial Perfusion and Flow Reserve in Cancer PatientsJosef J Fox, Audrey Mauguen, Kimiteru Ito, et al.
International Journal of Radiation Oncology, Biology, Physics|December 25, 2014
Predicting outcome in patients with rhabdomyosarcoma: role of [(18)f]fluorodeoxyglucose positron emission tomographyDana L Casey, Leonard H Wexler, Josef J Fox, et al.
Chest|May 7, 2014
Noncontrast perfusion single-photon emission CT/CT scanning: a new test for the expedited, high-accuracy diagnosis of acute pulmonary embolismYang Lu, Alice Lorenzoni, Josef J Fox, et al.
AJR. American Journal of Roentgenology|June 25, 2013
Pancreatic involvement in neuroblastoma with radiologic-pathologic correlation: a single-institution experienceDaniel G Rosenbaum, Sara J Abramson, Eithne DeLappe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2010
Prognostic value of baseline [18F] fluorodeoxyglucose positron emission tomography and 99mTc-MDP bone scan in progressing metastatic prostate cancerGustavo S P Meirelles, Heiko Schöder, Gregory C Ravizzini, et al.
International Journal of Radiation Oncology, Biology, Physics|May 8, 2012
Positron emission tomography (PET) evaluation after initial chemotherapy and radiation therapy predicts local control in rhabdomyosarcomaKavita V Dharmarajan, Leonard H Wexler, Somali Gavane, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 2012
Bone scan index: a quantitative treatment response biomarker for castration-resistant metastatic prostate cancerElizabeth R Dennis, Xiaoyu Jia, Irina S Mezheritskiy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 4, 2026
Diagnostic Value of Routine Delayed Pelvic Imaging for Patients with Biochemical Recurrence of Prostate Cancer Undergoing <sup>68</sup>Ga-PSMA PET/CTKaren Y Jia, Jonathan Kuten, Heather Y Jia, et al.
Radiology|January 31, 2014
Bone metastases in castration-resistant prostate cancer: associations between morphologic CT patterns, glycolytic activity, and androgen receptor expression on PET and overall survivalHebert Alberto Vargas, Cecilia Wassberg, Josef J Fox, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 4, 2016
Evaluation of Castration-Resistant Prostate Cancer with Androgen Receptor-Axis ImagingNeeta Pandit-Taskar, Darren R Veach, Josef J Fox, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 5, 2023
Long-Term Prognostic Value of <sup>82</sup>Rb PET/CT-Determined Myocardial Perfusion and Flow Reserve in Cancer PatientsJosef J Fox, Audrey Mauguen, Kimiteru Ito, et al.
International Journal of Radiation Oncology, Biology, Physics|December 25, 2014
Predicting outcome in patients with rhabdomyosarcoma: role of [(18)f]fluorodeoxyglucose positron emission tomographyDana L Casey, Leonard H Wexler, Josef J Fox, et al.
Chest|May 7, 2014
Noncontrast perfusion single-photon emission CT/CT scanning: a new test for the expedited, high-accuracy diagnosis of acute pulmonary embolismYang Lu, Alice Lorenzoni, Josef J Fox, et al.
AJR. American Journal of Roentgenology|June 25, 2013
Pancreatic involvement in neuroblastoma with radiologic-pathologic correlation: a single-institution experienceDaniel G Rosenbaum, Sara J Abramson, Eithne DeLappe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2010
Prognostic value of baseline [18F] fluorodeoxyglucose positron emission tomography and 99mTc-MDP bone scan in progressing metastatic prostate cancerGustavo S P Meirelles, Heiko Schöder, Gregory C Ravizzini, et al.
International Journal of Radiation Oncology, Biology, Physics|May 8, 2012
Positron emission tomography (PET) evaluation after initial chemotherapy and radiation therapy predicts local control in rhabdomyosarcomaKavita V Dharmarajan, Leonard H Wexler, Somali Gavane, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 2012
Bone scan index: a quantitative treatment response biomarker for castration-resistant metastatic prostate cancerElizabeth R Dennis, Xiaoyu Jia, Irina S Mezheritskiy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 4, 2026
Diagnostic Value of Routine Delayed Pelvic Imaging for Patients with Biochemical Recurrence of Prostate Cancer Undergoing <sup>68</sup>Ga-PSMA PET/CTKaren Y Jia, Jonathan Kuten, Heather Y Jia, et al.
Radiology|January 31, 2014
Bone metastases in castration-resistant prostate cancer: associations between morphologic CT patterns, glycolytic activity, and androgen receptor expression on PET and overall survivalHebert Alberto Vargas, Cecilia Wassberg, Josef J Fox, et al.
Pageof 4